Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and Neck

Clinical trial NCT07682675 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07682675
Sponsor: UNICANCER
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenoid Cystic Carcinoma of the Salivary Gland Recurrence Metastatic Disease

Start date: 2026-10-01
Primary completion: 2029-04-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.